MarketPulse
B

$BAYRY

6 articles found
2 positive
0 negative
4 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Global Antibiotics Market Poised for Steady Growth as Innovation Tackles Resistance Crisis

Global antibiotics market to grow from USD 55.60B in 2025 to USD 70.64B by 2031 at 4.07% CAGR, driven by antimicrobial resistance and innovation.
JNJMRKPFELLYSNY+4Asia Pacific growthpharmaceutical innovation
GlobeNewswire Inc.GlobeNewswire Inc.··Visiongain

Ophthalmic Drug Market to Reach $41.88B by 2026 Amid Innovation Wave

Global ophthalmic drug market projected to reach $41.88B by 2026, growing 7.9% annually driven by biologic therapies, advanced delivery systems, and AI-enabled diagnostics.
PFEABBVNVSALCRHHBY+3AMDbiologics
GlobeNewswire Inc.GlobeNewswire Inc.··Cytokinetics, Incorporated

Cytokinetics Launches MYQORZO Following FDA Approval, Guides 2026 Spending

Cytokinetics launches MYQORZO for heart disease post-FDA approval; guides $830-870M spending in 2026 with strong cash position supporting commercial expansion.
SNYBAYRYCYTKFDA approvalclinical trials
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Blood Plasma Derivatives Market to Double to $104B by 2033 on Rising Disease Prevalence

Blood plasma derivatives market to double to $104B by 2033, driven by rising disease prevalence and immunoglobulin demand across developed and emerging markets.
BAYRYTAKGRFSBAXmarket growthAsia-Pacific expansion
BenzingaBenzinga··Namrata Sen

Bayer Offers $7.25B Settlement to Resolve Roundup Cancer Litigation

Bayer proposes $7.25 billion settlement to resolve thousands of Roundup cancer lawsuits, with payments spread over 21 years.
BAYRYlitigationSupreme Court
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider Research

Uterine Fibroid Treatment Market Poised for 7.63% Annual Growth Through 2033

Global uterine fibroid treatment market projected to grow 7.63% annually through 2033, reaching $9.43 billion. Growth driven by high disease prevalence and minimally invasive surgical advances.
JNJPFEABBVSYKMDT+9market growthminimally invasive procedures